Latest Price Targets from the World's Best Analysts & Research Firms

Analyst & Firm Stock Price Price Target Upside
Downside
Rating Date
WF
301
Wells Fargo
Michael Turrin
CRM icon
Salesforce
CRM
$239B
$250.76 $265
6%
upside
Equal-Weight 3 days ago
WF
302
Wells Fargo
Michael Turrin
GTLB icon
GitLab
GTLB
$7.63B
$45.73 $55
20%
upside
Overweight 3 days ago
RC
303
RBC Capital
Rishi Jaluria
FIG
Figma, Inc.
FIG
$26.9B
$54.86 $65
18%
upside
Sector Perform 3 days ago
WF
304
Wells Fargo
Michael Turrin
FIG
Figma, Inc.
FIG
$26.9B
$54.86 $70
28%
upside
Equal-Weight 3 days ago
WF
305
Wells Fargo
Aaron Rakers
HPE icon
Hewlett Packard
HPE
$31B
$23.52 $26
11%
upside
Equal-Weight 3 days ago
WF
306
Wells Fargo
Tiago Fauth
WVE icon
Wave Life Sciences
WVE
$1.32B
$8.29 $18
117%
upside
Overweight 3 days ago
S
307
Scotiabank
Divya Goyal
TIXT icon
TELUS International
TIXT
$1.25B
$4.47 $4.50
1%
upside
Sector Perform 3 days ago
S
308
Scotiabank
Greg McGinniss
REXR icon
Rexford Industrial Realty
REXR
$10.2B
$42.89 $43
0%
upside
Sector Perform 3 days ago
CF
309
Cantor Fitzgerald
Jonathan Ruykhaver
GTLB icon
GitLab
GTLB
$7.63B
$45.73 $60
31%
upside
Overweight 3 days ago
CF
310
Cantor Fitzgerald
Matthew Vanvliet
CRM icon
Salesforce
CRM
$239B
$250.76 $325
30%
upside
Overweight 3 days ago
O
311
Oppenheimer
Ian Zaffino
FUN icon
Cedar Fair
FUN
$2.53B
$24.97 $40
60%
upside
Outperform 3 days ago
S&C
312
Stephens & Co.
Raj Kumar
PNTG icon
Pennant Group
PNTG
$840M
$24.29 $40
65%
upside
Overweight 3 days ago
B
313
Barclays
Raimo Lenschow
CXM icon
Sprinklr
CXM
$1.91B
$7.81 $8
2%
upside
Underweight 3 days ago
S&C
314
Stephens & Co.
Jeff Garro
PRVA icon
Privia Health
PRVA
$2.86B
$23.28 $32
37%
upside
Overweight 3 days ago
O
315
Oppenheimer
Edward Yang
ENTG icon
Entegris
ENTG
$12.4B
$81.98 $95
16%
upside
Perform 3 days ago
B
316
Barclays
Paul Kearney
M icon
Macy's
M
$4.64B
$17.33 $15
13%
downside
Equal-Weight 3 days ago
B
317
Barclays
Thomas O'Malley
CRDO icon
Credo Technology Group
CRDO
$24.4B
$140.82 $165
17%
upside
Overweight 3 days ago
O
318
Oppenheimer
Matthew Biegler
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$784M
$9.90 $23
132%
upside
Outperform 3 days ago
U
319
UBS
Karl Keirstead
GTLB icon
GitLab
GTLB
$7.63B
$45.73 $60
31%
upside
Buy 3 days ago
U
320
UBS
Radi Sultan
AI icon
C3.ai
AI
$2.15B
$15.62 $16
2%
upside
Neutral 3 days ago
U
321
UBS
Ashwani Verma
UTHR icon
United Therapeutics
UTHR
$18.1B
$400.52 $560
40%
upside
Buy 3 days ago
U
322
UBS
Jay Sole
M icon
Macy's
M
$4.64B
$17.33 $6.50
62%
downside
Sell 3 days ago
U
323
UBS
David Vogt
HPE icon
Hewlett Packard
HPE
$31B
$23.52 $23
2%
downside
Neutral 3 days ago
S
324
Susquehanna
Christopher Rolland
CRDO icon
Credo Technology Group
CRDO
$24.4B
$140.82 $165
17%
upside
Positive 3 days ago
JS
325
JMP Securities
Matthew J. Carletti
SKWD icon
Skyward Specialty Insurance
SKWD
$2.03B
$50.23 $70
39%
upside
Market Outperform 3 days ago